Skip to content

Prospective monocentric PMCF study after bilateral, combined implantation of a glistening-free, hydrophobic, rotationally asymmetric EDOF and multifocal intraocular lens based on the blended vision principle evaluating visual acuity and patient satisfaction

Prospective monocentric PMCF study after bilateral, combined implantation of a glistening-free, hydrophobic, rotationally asymmetric EDOF and multifocal intraocular lens based on the blended vision principle evaluating visual acuity and patient satisfaction - acumax-2020-03: Blended Vision Acunex Vario + Acunex VarioMax

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026782
Enrollment
30
Registered
2021-10-04
Start date
2021-03-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H28

Interventions

Group 1: Patients diagnosed with bilateral cataract and meets the in- and exclusion criteria are included in the study after detailed written and verbal explanations, after signing the declaration of

Sponsors

Teleon Surgical B.V.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: • Patient age > 40 years • Bilateral cataract / bilateral intervention • Expected post-operative corneal astigmatism = 0.75 D • Planned implantation in the capsular bag • photopic pupil size between 3 and 6 mm • Pupil decentering <0.8 mm (center shift) • Contact lens wear within the last 2 weeks before screening • Presence of a written declaration of informed consent from the patient

Exclusion criteria

Exclusion criteria: • Amblyopia, • Strabismus • Pregnancy • Zonulolysis • Keratoplasty • Irregular Corneal Astigmatism • Previous corneal refractive interventions or surgical glaucoma interventions • Diseases other than cataract, which may result in postoperative, monocular best-corrected distance vision <0.63 (decimal visual acuity) • Intraoperative complications • The patient's current active participation in another clinical trial

Design outcomes

Primary

MeasureTime frame
Binocular uncorrected visual acuity for near vision using ETDRS (Early Treatment of Diabethic Retinopathia Study) charts. Both eyes are examined on each patient. The visual acuity data are evaluated preoperatively and 1-7 days, 1, 6 and 12-24 months after cataract surgery.

Secondary

MeasureTime frame
- Uncorrected distant visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA, 66 cm), each monocular and binocular, uncorrected near visual acuity (UNVA, 40 cm) monocular using ETDRS (Early Treatment of Diabethic Retinopathia Study) charts preoperatively and 1-7 days, 1 and 6 months postoperatively - Corrected distance visual acuity (CDVA), corrected intermediate visual acuity (DCIVA, 66 cm), corrected near visual acuity (DCNVA, 40 cm) each monocular and binocular, using ETDRS (Early Treatment of Diabethic Retinopathia Study) charts preoperatively and 1, 6 and 12-24 months postoperatively - Subjective refraction using corrective glasses or phoropters preoperatively and 1, 6 und 12-24 months postoperatively - Defocus curve monocular and binocular, using ETDRS (Early Treatment of Diabethic Retinopathia Study) charts after 6 and 12-24 months postoperatively - Monocular contrast sensitivity measurements using Pelli Robson tables after 6 and 12-24 months postoperatively - Patient satisfaction using a questionnaire on optical quality after 6 and 12-24 months postoperatively

Countries

Germany

Contacts

Public ContactChristoph Thiemann

Augentagesklinik Spreebogen

christoph.thiemann@atk-spreebogen.de30 398098 20

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026